Your browser doesn't support javascript.
loading
A comparison of atenolol, labetalol, esmolol, and landiolol for altering human neutrophil functions.
Nishina, K; Akamatsu, H; Mikawa, K; Shiga, M; Obara, H; Niwa, Y.
Affiliation
  • Nishina K; Department of Anesthesiology and Intensive Care Unit, Kobe University School of Medicine, Kobe, Japan.
Anesth Analg ; 93(3): 641-4, 2001 Sep.
Article in En | MEDLINE | ID: mdl-11524332
IMPLICATIONS: Neutrophils play a pivotal role in the antibacterial host defense system. Atenolol, labetalol, esmolol, and landiolol at clinically relevant concentrations failed to change neutrophil functions. Our findings indicate that we may be able to use these beta-antagonists without great caution in clinical settings.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Adrenergic beta-Antagonists / Neutrophils Limits: Humans Language: En Journal: Anesth Analg Year: 2001 Document type: Article Affiliation country: Japan Country of publication: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Adrenergic beta-Antagonists / Neutrophils Limits: Humans Language: En Journal: Anesth Analg Year: 2001 Document type: Article Affiliation country: Japan Country of publication: United States